163 results on '"Liao, Laura"'
Search Results
2. Immunogenicity of Atezolizumab: Influence of Testing Method and Sampling Frequency on Reported Anti-drug Antibody Incidence Rates
3. Quantification of Ebola virus replication kinetics in vitro
4. Real-world experience of CAR T-cell therapy in older patients with relapsed/refractory diffuse large B-cell lymphoma
5. Tutorial on agent-based models in NetLogo applied to immunology and virology
6. Matching-adjusted Indirect Comparison of the Efficacy of Loncastuximab Tesirine Versus Treatment in the Chemoimmunotherapy Era for Relapsed/Refractory Diffuse Large B-cell Lymphoma
7. Characteristics and Clinical Outcomes of Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma Who Received At Least 3 Lines of Therapies
8. Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma
9. Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody
10. Quantifying the contribution of Fc-mediated effector functions to the antiviral activity of anti–HIV-1 IgG1 antibodies in vivo
11. Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
12. Within-host mathematical models of hepatitis B virus infection: Past, present, and future
13. Toward Early-Warning Detection of Gravitational Waves from Compact Binary Coalescence
14. Clinical outcomes of older and younger patients treated with loncastuximab tesirine in the LOTIS-2 clinical trial
15. ABCL-316 Health-Related Quality of Life and Tolerability in Patients With/Without Skin Toxicity During Loncastuximab Tesirine Treatment in a Phase 2 Clinical Trial (LOTIS-2)
16. ABCL-334 Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
17. Progress and trends in mathematical modelling of influenza A virus infections
18. Twelve-month discontinuation rates of levonorgestrel intrauterine system 13.5 mg and subdermal etonogestrel implant in women aged 18–44: A retrospective claims database analysis
19. Investigation of Relationships between Urinary Biomarkers of Phytoestrogens, Phthalates, and Phenols and Pubertal Stages in Girls
20. Publisher Correction: Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
21. Clinical and Economic Burden in Patients with Diagnosis of Peripheral Arterial Disease in a Claims Database in Japan
22. Real-World Outcomes in Relapsed/Refractory DLBCL Patients Who Received Polatuzumab Vedotin PLUS Bendamustine and Rituximab or Tafasitamab Plus Lenalidomide By Line of Therapy
23. Real-World Effectiveness and Economic Impact Associated with Chimeric Antigen Receptor T-Cell Therapy Among Older Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma in US
24. Mathematical models of Influenza A virus infections in vitro: Investigating defective interfering particles and virus release
25. Poster: ABCL-316 Health-Related Quality of Life and Tolerability in Patients With/Without Skin Toxicity During Loncastuximab Tesirine Treatment in a Phase 2 Clinical Trial (LOTIS-2)
26. Poster: ABCL-334 Long-Term Survival Projections of Loncastuximab Tesirine-Treated Patients in Relapsed or Refractory Diffuse Large B-Cell Lymphoma
27. Linear Oligostannanes: A Synthetic and TD-DFT Study
28. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform
29. Long-term survival projections of loncastuximab tesirine-treated patients in relapsed or refractory (R/R) diffuse large B-cell lymphoma (DLBCL).
30. Investigation of Relationships between Urinary Biomarkers of Phytoestrogens, Phthalates, and Phenols and Pubertal Stages in Girls
31. HSR22-171: Health-Related Quality of Life, Symptoms, and Tolerability of Loncastuximab Tesirine in Older Versus Younger Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma Treated in a Phase 2 Clinical Trial (LOTIS-2)
32. Modeling diverse genetic subtypes of lung adenocarcinoma with a next-generation alveolar type 2 organoid platform
33. Characteristics and Clinical Outcomes of Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma who Received at Least 3 Lines of Therapies
34. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
35. Characteristics and treatment patterns of relapsed/refractory diffuse large B-cell lymphoma in patients receiving ≥3 therapy lines in post-CAR-T era
36. Keap1 mutation renders lung adenocarcinomas dependent on Slc33a1
37. Resource use and costs in patients with relapsed/refractory diffuse large C-cell lymphoma who initiated a third-line therapy in the post CAR-T era: A longitudinal outlook.
38. CD8 Lymphocyte Depletion Enhances the Latency Reversal Activity of the SMAC Mimetic AZD5582 in ART-Suppressed Simian Immunodeficiency Virus-Infected Rhesus Macaques
39. Hospital Readmissions and Mortality Among Intubated and Mechanically Ventilated Adult Subjects With Pneumonia Due to Gram-Negative Bacteria
40. Characteristics and Treatment Patterns of Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma Who Received ≥3 Lines of Therapies
41. COMPARISON OF HEALTHCARE COSTS OF PATIENTS WITH PULMONARY ARTERIAL HYPERTENSTION WITH PHOSPHODIESTERASE-5 INHIBITOR FAILURE WHO SWITCHED TO RIOCIGUAT VS THOSE WHO AUGMENTED THERAPY
42. Exploring virus release as a bottleneck for the spread of influenza A virus infection in vitro and the implications for antiviral therapy with neuraminidase inhibitors
43. Glycaemic control and hypoglycaemia burden in patients with type 2 diabetes initiating basal insulin in Europe and the USA
44. IMMUNE-VIRAL DYNAMICS MODELING OF THE BASIS FOR INDIVIDUAL VARIATION IN COVID-19.
45. (In)validating experimentally derived knowledge about influenza A defective interfering particles
46. Outcomes and healthcare resource utilization associated with medically attended hypoglycemia in older patients with type 2 diabetes initiating basal insulin in a US managed care setting
47. Signalling in single cell wound healing
48. Modeling the roles of protein kinase Cβ and η in single-cell wound repair
49. Resource utilization in patients with breast cancer treated with generic versus branded docetaxel.
50. Childhood Obesity and Neighborhood Food-Store Availability in an Inner-City Community
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.